1)中川雅夫.本邦における播種性血管内凝固(DIC)の発症頻度・原因疾患に関する調査報告.厚生省特定疾患血液系疾患調査研究班血液凝固異常症分科会.平成10年研究業績報告書,1999:pp.57-64.
2)Sack GH Jr, et al. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 1977; 56: 1-37.
3)Varki A. Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 2007; 110: 1723-1729.
4)Gouin-Thibault I, Samama MM. Laboratory diagnosis of the thrombophilic state in cancer patients. Semin Thromb Hemost. 1999; 25: 167-172.
5)Levi M. Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol. 2009; 22: 129-136.
6)Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2012; 2: 1091-1099.
7)関義信.がん(固形がん)とDIC.朝倉英策(編著).臨床に直結する血栓止血学 改訂2版.中外医学社,2018:pp.309-315.
8)Seki Y, Wakaki K. Pathological findings in a case of bone marrow carcinosis due to gastric cancer complicated by disseminated intravascular coagulation and thrombotic microangiopathy. Int J Hematol. 2016; 104: 506-511.
9)Seki Y, et al. In vitro effect of cyclosporin A, mitomycin C and prednisolone on cell kinetics in cultured human umbilical vein endothelial cells. Thromb Res. 2005; 115: 219-228.
10)朝倉英策,他.日本血栓止血学会DIC診断基準 2017年版.日血栓止血会誌.2017;28:369-391.